Chugai Pharmaceutical Co (TSE:4519) EV-to-Revenue : 7.35 (As of May. 05, 2024)

View and export this data going back to 1956. Start your Free Trial

What is Chugai Pharmaceutical Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Chugai Pharmaceutical Co's enterprise value is 円7,617,009 Mil. Chugai Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was 円1,036,075 Mil. Therefore, Chugai Pharmaceutical Co's EV-to-Revenue for today is 7.35.

The historical rank and industry rank for Chugai Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:

TSE:4519' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.02 Med: 4.86 Max: 13.08
Current: 7.35

During the past 13 years, the highest EV-to-Revenue of Chugai Pharmaceutical Co was 13.08. The lowest was 2.02. And the median was 4.86.

TSE:4519's EV-to-Revenue is ranked worse than
84.08% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.36 vs TSE:4519: 7.35

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-05), Chugai Pharmaceutical Co's stock price is 円5094.00. Chugai Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was 円629.64. Therefore, Chugai Pharmaceutical Co's PS Ratio for today is 8.09.

Chugai Pharmaceutical Co EV-to-Revenue Historical Data

The historical data trend for Chugai Pharmaceutical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co EV-to-Revenue Chart

Chugai Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

7.56

11.01

5.67

4.00

7.24

Chugai Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															3.98	4.87	5.47	7.24	8.42

Competitive Comparison of Chugai Pharmaceutical Co's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chugai Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's EV-to-Revenue falls into.

Chugai Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Chugai Pharmaceutical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	7617009.139	/	1036075
	=	7.35

Chugai Pharmaceutical Co's current Enterprise Value is 円7,617,009 Mil.
Chugai Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,036,075 Mil.

Chugai Pharmaceutical Co (TSE:4519) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Chugai Pharmaceutical Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	5094.00	/	629.639
	=	8.09

Chugai Pharmaceutical Co's share price for today is 円5094.00.
Chugai Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円629.64.

Chugai Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Chugai Pharmaceutical Co (TSE:4519) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (TSE:4519) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

CHGCY:USA CHGCF:USA CUP:Germany

Address

1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324

Website

http://www.chugai-pharm.co.jp

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding Ltd, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and COVID-19.

Chugai Pharmaceutical Co (TSE:4519) Headlines

No Headlines